AllDocs -> cancers

page 1 of 2 Do You Have Cancer in Your Family? Do You Have Cancer in Your Family? Cancer genetic counseling may be helpful to you. Many people have at least one relative with cancer . Cancer is very common, but only 5 to 10% of people with cancer have an inherited cancer . ?Inherited? refers to something that ?runs in families? and may be passed down from parents to children. Genetic tests are available for some inherited cancers . This brochure answers some common questions about inherited cancer and genetic testing. A cancer genetics specialist can discuss these issues in more detail and address other concerns. Cancer genetics specialists may include genetic counselors, genetics doctors, oncologists, and advanced practice nurses with special training in cancer genetics. Why are some cancers inherited? Inherited cancer is caused by a change ...

Cancer in Vermont A report of 1995-1999 cancer incidence data from the Vermont Cancer Registry Vermont Department of Health March 2003 b b b b b b b b b b b b Page 2 b Contents The Disease of Cancer . 2 Female Cancer Incidence Table . 6 Female Cancer Mortality Table . 7 Male Cancer Incidence Table 8 Male Cancer Mortality Table 9 Breast Cancer .. 10 Colorectal Cancer .. 12 Lung Cancer . 14 Melanoma . 16 Prostate Cancer .. 18 Cervical Cancer 19 The Vermont Cancer Registry 20 Statistical Terms & Methods .. 21 Vermont Cancer Tables Age-adjusted Cancer Incidence Rates Table 22 Age-adjusted Cancer Mortality ...

Priorities for Action in Cancer Control 2001œ2003 Priorities for Action in Cancer Control 2001œ2003 cover1 14/1/02 5:01 PM Page 2 Page 2 © Commonwealth of Australia 2001 ISBN 0 642 50377 X This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. All other rights are reserved. Requests and inquiries concerning reproduction and rights should be addressed to the Manager, Copyright Services, Information Services, GPO Box 1920, Canberra ACT 2601 or by e-mail Cwealthcopyright@finance.gov.au. Publication approval number: 2979 cover1 14/1/02 5:01 PM Page 3 Page 3 Priorities for Action in Cancer Control 2001œ2003 ...

Cancer What is cancer ? Cancer is a general term used to describe a large group of diseases, all of which result from uncontrolled and abnormal cell division, and which may arise in any organ or tissue of the body. The body is made up of millions of tiny cells (the basic building blocks of the body). Normally cells replace themselves in an orderly manner whenever necessary so that growth occurs and damaged or worn out tissues are replaced. Sometimes the cells don’t divide and grow normally. Instead they continue to divide even when they don’t need to. They grow into a lump called a tumour that may be benign or malignant. • A benign tumour is not cancer . Benign cells do not spread and can usually be completely removed. They are not likely to recur and do not usually present a serious threat to health. • A malignant tumour is cancer . Malignant cells can invade and destroy surrounding ...

www.danielchapterone.com 1-800-504-5511 Cancer Newsletter, Millenium Edition, 2002 Page 2 Daniel Chapter One® Founder of BioMolecular Nutrition ™ “No type of cancer is to be taken lightly. If it is not treated properly and completely removed, it will continue to spread and eventually prove fatal. The first step is to cleanse the bloodstream by thoroughly relieving constipation and making all the organs of elimination active I have been asked many times what my cure for cancer is. Here it is in a nutshell: correct food, herbs, water, fresh air, massage, sunshine, and exercise, rest. If cancer is suspected, clean out the system, and get a new supply of pure blood. There are nonpoisonous herbs that will purify the blood and kill malignant growths internally or externally, leaving no bad after-effects. Cancer will not live in a system when the ...

Cancer Facts & Figures for AfricanAmericans 2003-2004 Page 2 Contents Cancer Statistics for African Americans 1 Selected Cancers 7 Risk Factor Statistics 11 Tobacco Use 11 Overweight, Obesity, and Physical Activity 12 Use of Screening Tests 15 Screening Guidelines 17 Sources of Statistics 18 References 19 Acknowledgments The production of this report would not have been possible without the efforts of Cheryll Cardinez, MSPH; Vilma Cokkinides, PhD, MSPH; Wendi Klevan; Taylor Murray; Dana Russotto, MPH; Susan Summers; Michael Thun, MD, MS; Janet Weaver; and Harriet Zoller. Cancer Facts & Figures for African Americans is a publication of the American Cancer Society, Atlanta, Georgia. For more information contact: Asma Ghafoor, MPH ...

D IVISION of U NIVERSITY A DVANCEMENT • O FFICE of U NIVERSITY D EVELOPMENT 208 West Franklin Street Campus Box 6100 • Chapel Hill, NC 27599-6100 • FAX: 919-962-2387 • www.carolinafirst.unc.edu most creative young minds to become tomorrow’s leaders in cancer research and care. Your Help Makes a Difference Private support has helped make Lineberger one of the nation’s best comprehensive cancer centers. These funds provide the resources and flexibility critical for attracting outstanding faculty, investing in new technology and research and training the next generation of scientists, physicians and public health experts. As part of the Carolina First Campaign, the UNC Lineberger Comprehensive Cancer Center seeks to raise $50 ...

1 Statement of Endorsement : Population-Based Colorectal Cancer Screening Position The Council of the Canadian Strategy for Cancer Control has reviewed the recommendations made by the National Committee on Colorectal Cancer Screening (NCCCS), an Expert Panel supported by Health Canada, which included members from provinces and key organizations from across the country. To access the report, please go to: http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/ncccs-cndcc/ccsrec_e.html. The Council fully endorses and supports the NCCCS’s recommendations that include the need for provinces to develop and implement high quality, population-based colorectal cancer screening programs. Their recommendation is based on strong clinical trial evidence, which supports that fecal occult blood screening could reduce colorectal cancer mortality by 15–33% in a targeted population of 50–74 ...

Cisco Systems, Inc. All contents are Copyright © 1992–2003 Cisco Systems, Inc. All rights reserved. Important Notices and Privacy Statement. Page 1 of 5 Success Story Cancer Therapy & Research Center—Cisco IP Communications Delivers Reliable, High-Performance Solutions that Improve the Quality of Patient Care Background The Cancer Therapy & Research Center (CTRC), of San Antonio, TX, is a world-class provider of outpatient cancer therapies. Founded in 1974, CTRC offers radiation and medical oncology services to San Antonio’s four largest hospitals and maintains major cancer research facilities. CTRC serves approximately 200-plus radiology patients every day and logs more than 100,000 visits each year. These patients depend on this facility for state-of-the-art therapy, other outpatient oncology services, and advanced scanning and diagnostic services. ...

791 INTRODUCTION In the past decade, tremendous strides have been made in understanding the cellular changes associated with the development of cancer in humans. 1 This has resulted in improved techniques for diagnosis and treatment of malignancies, including oral cancers . Health profession- als have been alerted to the importance of the relationship between complete examination of the head and neck area, early cancer detection, and survival of afflicted individu- als. Additionally, major emphasis has been placed on the prevention of malignancies by identification and control of factors such as tobacco use and alcohol consumption, which are known to be associated with carcinogenic tis- sue changes. 2-5 Chemopreventive agents such as synthetic retinoids have been used successfully in reversing oral leukoplakic lesions before malignant transformation. ...

Nutrition & Prostate Cancer Natalie Ledesma, MS, RD Cancer Resource Center UCSF Comprehensive Cancer Center University of California, San Francisco Scientific evidence suggests that differences in diet and lifestyle may account in large part for the variability of prostate cancer rates in different countries [1]. Good nutrition may reduce the incidence of prostate cancer and help reduce the risk of pros- tate cancer progression. There are many studies currently being conducted to help further understand how diet and prostate cancer are related. We do know, however, that improved nutrition reduces risk of heart disease, diabetes, and obesity, and usually improves overall quality of life. It is estimated that one-third of cancer deaths in the U.S. can be attributed to diet in adulthood, including diet’s effect on obesity [2]. Additionally, a healthy diet ...

Last revised: 2/19/03 UM Cancer Center Patient Education Document #0163 Feb 03 Ed. http://www. cancer .med.umich.edu/learn/percpathways.htm 1 University of Michigan Comprehensive Cancer Center Patient Education Resource Center (PERC) INFORMATION GUIDE Colorectal Cancer Prevention & Early Detection The purpose of this information guide is to direct interested individuals to quality sources of information about colorectal cancer prevention and early detection This list is not meant to be comprehensive, but rather to provide starting points for information seeking. The materials can be found at the Patient Education Resource Center at the University of Michigan Comprehensive Cancer Center located on the B1 level room 361. Pamphlets Free copies available in the Patient Education Resource Center room B1-361 ...

NCMJ January/February 2003, Volume 64 Number 1 11 T HE DECLINE IN CERVICAL CANCER inci- dence and mortality seen over the past several decades 1 is perhaps one of the success stories of screening and early detection in the field of cancer control. The American Cancer Society estimates that in the United States in 2001 there were 12,900 cases of invasive cervical cancer and 4,400 deaths, representing only 2.0% of incident cancers in women and 1.6% of female cancer deaths. 2 Although no randomized trials have been conducted, observational studies suggest that the introduction of Papanicoloau (Pap) testing is responsible for the decline in cervical cancer incidence. 3, 4 Moreover, the five-year survival rate has not changed significantly since the 1970s, suggesting that the decline in mortality is attributable ...

ASSESSMENT OF CANCER RISK DUE TO ACRYLAMIDE INTAKE FROM COFFEE CONSUMPTION Report from the Scientific Committee of the Norwegian Food Control Authority 13 December 2002 Introduction The Norwegian Food Control Authority (henceforth referred to as SNT) has performed analyses of the acrylamide levels in coffee products present on the Norwegian market. Based on the results of these analyses, SNT asked the Advisory Group on Contaminants of its Scientific Committee the following questions: • Which level of risk does the intake of acrylamide from coffee represent for the Norwegian population? • What total risk does intake of acrylamide from foods and beverages represent for the Norwegian population? • Which food groups contribute most to the total risk? In their reply to these questions the Advisory Group on Contaminants made reference to the report ...

HEREDITARY CANCER PROGRAM A Guide for Patients & Health Care Providers MSU Division of Human Genetics Department of Pediatrics and Human Development B240 Life Sciences Building East Lansing, MI 48824-1317 Phone: (517) 355-1297 MSU Clinical Genetics Page 2 The Hereditary Cancer Program at Michigan State University is dedicated to providing genetic counseling and education to individuals with a significant family history of cancer . Our clinic is staffed by a medical geneticist and genetic counselor. The initial genetic counseling session includes: • Extensive review of the family history • Personalized risk assessment • Education about genetics and hereditary cancer syndromes • Discussion of available screening and management options • Explanation of genetic testing ...

1 To: All HAs, PCGs, PCTs, cancer network managers Cc: Regional Cancer Co-ordinators Primary care cancer leads Last year in the Cancer Plan we announced a joint initiative between the Department of Health and Macmillan Cancer Relief to invest a total of £3million each year for three years for the appointment of a lead clinician for cancer within each PCG/T. This funding is to enable the lead clinician to have dedicated time to contribute to the development of cancer networks and raising the standard of cancer care within the PCG/T. This letter confirms that from April 2001, each Health Authority will receive £5,000 per PCG/T to allocate for funding the appointment of a primary care cancer lead in each PCG/T. A separate letter setting out the cash limit adjustments will be sent to each HA shortly. Many PCG/Ts already have a nominated cancer lead and may wish to ...

NCMJ September/October 2002, Volume 63 Number 5 241 Running the Numbers A Periodic Feature to Inform North Carolina Healthcare Professionals About Current Topics in Health Statistics Paul A. Buescher, PhD Cervical Cancer Disparities Between African-American and White Women in North Carolina We examined cervical cancer incidence, stage at diagnosis, and mortality among African-American and white women in North Carolina, using descriptive data from the North Carolina Central Cancer Registry and from death certificates. Describing racial differences in cervical cancer allows targeting of resources and health improvement programs toward populations most in need. The table shows the number of cervical cancer cases and deaths, and rates per 100,000 female population, by age and race for North Carolina for 1995-1998. New Cases Deaths ...

Cervical cancer is the seventh most common cancer among women. It is estimated that 13,000 new cases will be diagnosed and approximately 4,000 deaths will occur in the United States this year. Since the Pap test (sometimes called a Pap smear) was introduced in the 1950’s, cervical cancer is more likely to be detected in its early curable stage. The cervix is the lower part of the uterus. What you need to know about CERVICAL CANCER Many cases of cervical cancer are associated with known risk factors for the disease which can be modified. Screening History: Women who have not regularly had a Pap test are at increased risk of cervical cancer . In particular, many women over age 60 have not had regular Pap tests and are at increased risk. Receiving regular pelvic exams and Pap tests are the most important steps in preventing cervical cancer . Abnormal ...

Established in 1998, MACGN is part of a national network of cancer genet- ics centers learning more about the ge- netic basis of cancer susceptibility and translating this new knowledge to pa- tient care. Sponsored by the National Cancer Institute, it is one of eight cen- ters around the country. MACGN is located at the Johns Hopkins Univer- sity in Baltimore, Maryland. The network has established a registry, or listing, of individuals with a per- sonal or family history of cancer . These individuals may be invited to join as potential participants in studies that will address issues such as: s Prevalence of inherited mutations of familial cancer genes in different populations s Determinants of cancer develop- ment in individuals with inherited mutations s Environmental exposures that inter- act with ...

NON–SMALL-CELL LUNG CANCER ,MESOTHELIOMA,AND THYMOMA 123 CHAPTER 7 Non–small-cell lung cancer ,mesothelioma, and thymoma Robert J.McKenna,Jr., MD ,Benjamin Movsas, MD ,Dong M.Shin, MD , and Fadlo R. Khuri, MD In the United States, lung cancer has been the leading cause of cancer death in men for years, and since 1988, it has become the number-one cause of cancer death in women. It is estimated that 173,770 new cases of lung cancer will be diagnosed in 2004, and 160,440 deaths due to this disease will occur. This ex- ceeds the combined number of deaths from the second, third, and fourth lead- ing causes of cancer (breast, prostate, and colon cancer , respectively). Lung cancer appears to develop from a stem cell that can differentiate along multiple lines. Although multiple cell types ...

CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS of CANCER REGISTRY DATA, 1979-2000, FOR DOVER TOWNSHIP (OCEAN COUNTY), NEW JERSEY Technical Report January 2003 Division of Epidemiology, Environmental and Occupational Health Consumer and Environmental Health Services In Cooperation with the Agency for Toxic Substances and Disease Registry James E. McGreevey Clifton R. Lacy, M.D. Governor Commissioner Page 2 CHILDHOOD CANCER INCIDENCE UPDATE: A REVIEW AND ANALYSIS OF CANCER REGISTRY DATA, 1979-2000, FOR DOVER TOWNSHIP (OCEAN COUNTY), NEW JERSEY Final Technical Report prepared by: Michael Berry Patricia Haltmeier Jerald Fagliano New Jersey Department of Health and Senior Services Division of Epidemiology, Environmental and Occupational ...

What is Colorectal Cancer ? Colorectal cancer is cancer that occurs in the colon or rectum. Sometimes it is called colon cancer , for short. As the drawing shows,the colon is the large intestine or large bowel. The rectum is the passageway that connects the colon to the anus. It’s the Second Leading Cancer Killer Colorectal cancer is the second leading cancer killer in the United States,but it doesn’t have to be. If everybody age 50 or older had regular screening tests,at least one-third of deaths from this cancer could be avoided. So if you are 50 or older,start screening now. Who Gets Colorectal Cancer ? • Both men and women can get colorectal cancer . • Colorectal cancer is most often found in people 50 and older. • The risk for getting colorectal cancer increases with age. ...

CDC publication #99-6948. September 2001 For more information about colorectal cancer ,visit www.cdc.gov/ cancer /ScreenforLife . Or call the National Cancer Institute’s Cancer Information Service: 1-800-4- CANCER . For TTY call 1-800-332-8615 . To find out about Medicare coverage,call 1-800-MEDICARE (1-800-633-4227) . Types of Screening Tests Several different screening tests can be used to test for polyps or colorectal cancer . Each can be used alone. Sometimes they are used in combination with each other. Fecal Occult Blood Test (FOBT) or Stool Test - A test you do at home using a test kit you get from your health care provider. You put stool samples on test cards,then return the cards to the doctor or a lab. This test checks for ...

CANCER AMONG CURRENT AND FORMER WORKERS AT NATIONAL SEMICONDUCTOR (UK) LTD, GREENOCK: Results of an investigation by the Health and Safety Executive HSE Health & Safety Executive Page 2 Damien M. McElvenny, MSc Andrew J. Darnton, BSc John T. Hodgson, MSc Simon D. Clarke, PhD Richard C. Elliott, BSc, FRCSEd John Osman, MRCP, FFOM (Hon) HSE BOOKS CANCER AMONG CURRENT AND FORMER WORKERS AT NATIONAL SEMICONDUCTOR (UK) LTD, GREENOCK: Results of an investigation by the Health and Safety Executive Page 3 ii © Crown copyright 2001 Applications for reproduction should be made in writing to: Copyright Unit, Her Majesty’s Stationery Office, St Clements House, 2-16 Colegate, Norwich NR3 1BQ First ...

Epidemiologic Studies of Cellular Telephones and Cancer Risk – A Review 2002:16 JOHN D. BOICE, JR. AND JOSEPH K. MCLAUGHLIN Page 2 SSI rapport : 2002:16 september 2002 ISSN 0282-4434 AUTHOR/ FÖRFATTARE: John D. Boice, Jr., Joseph K. McLaughlin. AFFILIATION : International Epidemiology Institute and Vanderbilt University School of Medicine and Vanderbilt-Ingram Cancer Center. International Epidemiology Institute, 1455 Research Blvd, Suite 550, Rockville, MD 20850 USA. TITLE : Epidemiologic Studies of Cellular Telephones and Cancer Risk, – A Review. SUMMARY : Cellular telephones emit and receive radiofrequency (RF) signals between about 450 and 2200 MHz which fall in the microwave region of the electromagnetic spectrum. A RF wave from a cellular telephone contains billions ...

G EORGETOWN U NIVERSITY M EDICAL C ENTER lombardi LOMBARDI CANCER CENTER RESEARCH • EDUCATION • TREATMENT • February 2001 information packet Cancer Assessment and Risk Evaluation care Page 2 T he CARE ( Cancer Assessment and Risk Evaluation) Program is a genetic counseling and testing program offered by the Lombardi Cancer Center at Georgetown University Medical Center. A component of the CARE program is known as PATH (Personal Aid to Health). This free research study is supported by a grant from the National Institutes of Health and the National Cancer Institute. Participation in CARE/PATH Through the program, each participant meets with a genetic counselor or nurse educator to discuss: • a detailed family history and risk ...

The APC is the Annual Percent Change based on rates age-adjusted to the 2000 U.S. standard population by 5-year age groups using the Joinpoint Regression Program. a Trends are from the SEER 9 areas. b Trends are from the NCHS public use data file. ’ The APC is significantly different from zero (p<.05). Table XX-1 OVARY CANCER (Invasive) TRENDS IN SEER INCIDENCE a AND U.S. MORTALITY b USING THE JOINPOINT REGRESSION PROGRAM, 1973-1999 WITH UP TO THREE JOINPOINTS BY RACE AND AGE All Races Whites Blacks Year APC Year APC Year APC SEER Cancer Incidence a Age - All Ages 1973-86 -0.3 1973-86 -0.2 1973-99 0.4 1986-89 5.0 1986-89 5.4 1989-99 -0.7 ’ 1989-99 -0.7 ’ Age - Under 65 1973-86 -1.2 ’ 1973-82 ...

The APC is the Annual Percent Change based on rates age-adjusted to the 2000 U.S. standard population by 5-year age groups using the Joinpoint Regression Program. a Trends are from the SEER 9 areas. b Trends are from the NCHS public use data file. ’ The APC is significantly different from zero (p<.05). Table XVI-1 MELANOMA OF SKIN (Invasive) TRENDS IN SEER INCIDENCE a AND U.S. MORTALITY b USING THE JOINPOINT REGRESSION PROGRAM, 1973-1999 WITH UP TO THREE JOINPOINTS BY RACE AND SEX All Races Whites Blacks Year APC Year APC Year APC SEER Cancer Incidence a Sex - Male and Female 1973-81 6.1 ’ 1973-81 6.5 ’ 1973-99 0.7 1981-99 2.8 ’ 1981-99 3.0 ’ Sex - Male 1973-85 5.7 ’ 1973-85 6.0 ’ 1973-99 2.8 ...

The APC is the Annual Percent Change based on rates age-adjusted to the 2000 U.S. standard population by 5-year age groups using the Joinpoint Regression Program. a Trends are from the SEER 9 areas. b Trends are from the NCHS public use data file. ’ The APC is significantly different from zero (p<.05). Table XXII-1 PROSTATE CANCER (Invasive) TRENDS IN SEER INCIDENCE a AND U.S. MORTALITY b USING THE JOINPOINT REGRESSION PROGRAM, 1973-1999 WITH UP TO THREE JOINPOINTS BY RACE AND AGE All Races Whites Blacks Year APC Year APC Year APC SEER Cancer Incidence a Age - All Ages 1973-88 2.7 ’ 1973-88 2.8 ’ 1973-89 2.1 ’ 1988-92 16.2 ’ 1988-92 16.1 ’ 1989-92 20.6 ’ 1992-95 -11.7 ’ 1992-95 -12.8 ’ 1992-96 ...

SEER Cancer Statistics Review 1973-1999 National Cancer Institute Complete and Limited Duration Cancer Prevalence Estimates Angela Mariotto 1 , Anna Gigli 2 , Riccardo Capocaccia 3 , Andrea Tavilla 3 , Limin X. Clegg 1 , Michael Depry 4 , Steve Scoppa 4 , Lynn A. G. Ries 1 , Julia H. Rowland 1 , Gina Tesauro 1 , Eric J. Feuer 1 1 National Cancer Institute, National Institutes of Health, Bethesda, USA 2 Institute for Population Research and Social Policies, National Research Council, Rome, Italy 3 Istituto Superiore di Sanita’, Rome, Italy 4 Information Management Services, Inc., Silver Spring, USA Introduction Prevalence is an indicator of primary interest in public ...